These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30649490)

  • 1. Molecular and translational advances in meningiomas.
    Suppiah S; Nassiri F; Bi WL; Dunn IF; Hanemann CO; Horbinski CM; Hashizume R; James CD; Mawrin C; Noushmehr H; Perry A; Sahm F; Sloan A; Von Deimling A; Wen PY; Aldape K; Zadeh G;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i4-i17. PubMed ID: 30649490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?
    Strassner C; Buhl R; Mehdorn HM
    Neurol Res; 2009 Jun; 31(5):478-82. PubMed ID: 19500450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.
    Robert SM; Vetsa S; Nadar A; Vasandani S; Youngblood MW; Gorelick E; Jin L; Marianayagam N; Erson-Omay EZ; Günel M; Moliterno J
    J Neurooncol; 2022 Jan; 156(2):205-214. PubMed ID: 34846640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of meningiomas.
    Buerki RA; Horbinski CM; Kruser T; Horowitz PM; James CD; Lukas RV
    Future Oncol; 2018 Sep; 14(21):2161-2177. PubMed ID: 30084265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningiomas: Overview and New Directions in Therapy.
    Wang N; Osswald M
    Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in multidisciplinary therapy for meningiomas.
    Brastianos PK; Galanis E; Butowski N; Chan JW; Dunn IF; Goldbrunner R; Herold-Mende C; Ippen FM; Mawrin C; McDermott MW; Sloan A; Snyder J; Tabatabai G; Tatagiba M; Tonn JC; Wen PY; Aldape K; Nassiri F; Zadeh G; Jenkinson MD; Raleigh DR;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i18-i31. PubMed ID: 30649489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningioma.
    Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
    Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
    World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of atypical and anaplastic meningiomas: a review.
    Modha A; Gutin PH
    Neurosurgery; 2005 Sep; 57(3):538-50; discussion 538-50. PubMed ID: 16145534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory groove meningioma.
    Adappa ND; Lee JY; Chiu AG; Palmer JN
    Otolaryngol Clin North Am; 2011 Aug; 44(4):965-80, ix. PubMed ID: 21819883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial Meningiomas: A 30-Year Experience and Literature Review.
    Mehdorn HM
    Adv Tech Stand Neurosurg; 2016; (43):139-84. PubMed ID: 26508409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?
    Lunsford LD
    J Neurosurg; 1994 Feb; 80(2):187-90. PubMed ID: 8283254
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic landscape of intracranial meningiomas.
    Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
    J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of malignant meningiomas: diagnosis, characteristics, and treatment.
    Hanft S; Canoll P; Bruce JN
    J Neurooncol; 2010 Sep; 99(3):433-43. PubMed ID: 20730473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality Therapy of Patients with Refractory Meningiomas.
    Ahmad H; Schiff D
    Curr Treat Options Oncol; 2019 May; 20(6):50. PubMed ID: 31073797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current experimental therapies for atypical and malignant meningiomas.
    Corona AM; Di L; Shah AH; Crespo R; Eichberg DG; Lu VM; Luther EM; Komotar RJ; Ivan ME
    J Neurooncol; 2021 Jun; 153(2):203-210. PubMed ID: 33950341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
    Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
    Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.